Allegro

The AI engine Fit Assessment

Beta

Allegro is a company focused on developing advanced biomedical technologies, particularly in the fields of rheumatology and orthopedics. They utilize nanotechnology to create innovative treatments for chronic degenerative diseases, including a disease-modifying therapy for osteoarthritis.

Blurb

Game-changing polypeptide therapies for rheumatology.

HQ Location

Liège (Belgium)

Founded

2021

Employees

11 - 50

Total funding raised

$7.73M

Last Funding Event

Seed, $6.04M, April 25, 2023

Smart insights

Not available

Developer of a nanotechnology platform designed for rheumatology, immunology, and chronic degenerative diseases. The company offers hydrogel injection that restores the mechanics of the joint, which is the fundamental cause of osteoarthritis, enabling researchers to invent a nanotechnology scaffold for orthopedics, rheumatology, and regenerative medicine.